Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases

Antonio Di Sabatino, Federico Biagi, Marco Lenzi, Luca Frulloni, Marco Vincenzo Lenti, Paolo Giuffrida, Gino Roberto Corazza

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

The progressively growing knowledge of the pathophysiology of a number of immune-mediated gastrointestinal and liver disorders, including autoimmune atrophic gastritis, coeliac disease, autoimmune enteropathy, inflammatory bowel disease, autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis and autoimmune pancreatitis, together with the improvement of their detection methods have increased the diagnostic power of serum antibodies. In some cases – coeliac disease and autoimmune atrophic gastritis – they have radically changed gastroenterologists’ diagnostic ability, while in others – autoimmune hepatitis, inflammatory bowel disease and autoimmune pancreatitis – their diagnostic performance is still inadequate. Of note, serum antibody misuse in clinical practice has raised a number of controversies, which may generate confusion in the diagnostic management of the aforementioned disorders. In this review, we critically re-evaluate the usefulness of serum antibodies as biomarkers of immune-mediated gastrointestinal and liver disorders, and discuss their pitfalls and merits.

Original languageEnglish
Pages (from-to)947-956
Number of pages10
JournalDigestive and Liver Disease
Volume49
Issue number9
DOIs
Publication statusPublished - Sep 1 2017

Fingerprint

Gastrointestinal Diseases
Liver Diseases
Atrophic Gastritis
Autoimmune Hepatitis
Biomarkers
Celiac Disease
Inflammatory Bowel Diseases
Pancreatitis
Antibodies
Serum
Sclerosing Cholangitis
Cholangitis
Liver

Keywords

  • Autoimmune atrophic gastritis
  • Autoimmune liver disease
  • Autoimmune pancreatitis
  • Coeliac disease
  • Inflammatory bowel disease

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. / Di Sabatino, Antonio; Biagi, Federico; Lenzi, Marco; Frulloni, Luca; Lenti, Marco Vincenzo; Giuffrida, Paolo; Corazza, Gino Roberto.

In: Digestive and Liver Disease, Vol. 49, No. 9, 01.09.2017, p. 947-956.

Research output: Contribution to journalReview article

Di Sabatino, Antonio ; Biagi, Federico ; Lenzi, Marco ; Frulloni, Luca ; Lenti, Marco Vincenzo ; Giuffrida, Paolo ; Corazza, Gino Roberto. / Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. In: Digestive and Liver Disease. 2017 ; Vol. 49, No. 9. pp. 947-956.
@article{3f8f576976e14131adb8745b1853787e,
title = "Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases",
abstract = "The progressively growing knowledge of the pathophysiology of a number of immune-mediated gastrointestinal and liver disorders, including autoimmune atrophic gastritis, coeliac disease, autoimmune enteropathy, inflammatory bowel disease, autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis and autoimmune pancreatitis, together with the improvement of their detection methods have increased the diagnostic power of serum antibodies. In some cases – coeliac disease and autoimmune atrophic gastritis – they have radically changed gastroenterologists’ diagnostic ability, while in others – autoimmune hepatitis, inflammatory bowel disease and autoimmune pancreatitis – their diagnostic performance is still inadequate. Of note, serum antibody misuse in clinical practice has raised a number of controversies, which may generate confusion in the diagnostic management of the aforementioned disorders. In this review, we critically re-evaluate the usefulness of serum antibodies as biomarkers of immune-mediated gastrointestinal and liver disorders, and discuss their pitfalls and merits.",
keywords = "Autoimmune atrophic gastritis, Autoimmune liver disease, Autoimmune pancreatitis, Coeliac disease, Inflammatory bowel disease",
author = "{Di Sabatino}, Antonio and Federico Biagi and Marco Lenzi and Luca Frulloni and Lenti, {Marco Vincenzo} and Paolo Giuffrida and Corazza, {Gino Roberto}",
year = "2017",
month = "9",
day = "1",
doi = "10.1016/j.dld.2017.06.010",
language = "English",
volume = "49",
pages = "947--956",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "9",

}

TY - JOUR

T1 - Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases

AU - Di Sabatino, Antonio

AU - Biagi, Federico

AU - Lenzi, Marco

AU - Frulloni, Luca

AU - Lenti, Marco Vincenzo

AU - Giuffrida, Paolo

AU - Corazza, Gino Roberto

PY - 2017/9/1

Y1 - 2017/9/1

N2 - The progressively growing knowledge of the pathophysiology of a number of immune-mediated gastrointestinal and liver disorders, including autoimmune atrophic gastritis, coeliac disease, autoimmune enteropathy, inflammatory bowel disease, autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis and autoimmune pancreatitis, together with the improvement of their detection methods have increased the diagnostic power of serum antibodies. In some cases – coeliac disease and autoimmune atrophic gastritis – they have radically changed gastroenterologists’ diagnostic ability, while in others – autoimmune hepatitis, inflammatory bowel disease and autoimmune pancreatitis – their diagnostic performance is still inadequate. Of note, serum antibody misuse in clinical practice has raised a number of controversies, which may generate confusion in the diagnostic management of the aforementioned disorders. In this review, we critically re-evaluate the usefulness of serum antibodies as biomarkers of immune-mediated gastrointestinal and liver disorders, and discuss their pitfalls and merits.

AB - The progressively growing knowledge of the pathophysiology of a number of immune-mediated gastrointestinal and liver disorders, including autoimmune atrophic gastritis, coeliac disease, autoimmune enteropathy, inflammatory bowel disease, autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis and autoimmune pancreatitis, together with the improvement of their detection methods have increased the diagnostic power of serum antibodies. In some cases – coeliac disease and autoimmune atrophic gastritis – they have radically changed gastroenterologists’ diagnostic ability, while in others – autoimmune hepatitis, inflammatory bowel disease and autoimmune pancreatitis – their diagnostic performance is still inadequate. Of note, serum antibody misuse in clinical practice has raised a number of controversies, which may generate confusion in the diagnostic management of the aforementioned disorders. In this review, we critically re-evaluate the usefulness of serum antibodies as biomarkers of immune-mediated gastrointestinal and liver disorders, and discuss their pitfalls and merits.

KW - Autoimmune atrophic gastritis

KW - Autoimmune liver disease

KW - Autoimmune pancreatitis

KW - Coeliac disease

KW - Inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=85024499871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024499871&partnerID=8YFLogxK

U2 - 10.1016/j.dld.2017.06.010

DO - 10.1016/j.dld.2017.06.010

M3 - Review article

AN - SCOPUS:85024499871

VL - 49

SP - 947

EP - 956

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 9

ER -